MDxHealth SA
MDXH
View Detailed Chart
3.335USD
+0.185+5.87%
Market hours （ET）Quotes delayed by 15 min
165.07MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+5.87%
5 Days
+0.45%
1 Month
+0.45%
6 Months
+68.18%
Year to Date
+40.72%
1 Year
+47.57%
View Detailed Chart
TradingKey Stock Score of MDxHealth SA
Currency: USD Updated: 2025-12-19Key Insights
MDxHealth SA's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered undervalued, ranking 99/404 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at 7.04.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
MDxHealth SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
6
analysts
Strong Buy
Current Rating
6.040
Target Price
+325.35%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
MDxHealth SA Highlights
StrengthsRisks
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 143.02% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 90.05M.
Fairly Valued
The company’s latest PE is -3.16, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 21.80M shares, decreasing 9.10% quarter-over-quarter.
Held by James Simons
Star Investor James Simons holds 202.80K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 0.58.
MDxHealth SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
MDxHealth SA Info
MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.
Ticker SymbolMDXH
CompanyMDxHealth SA
CEOMr. Michael K. McGarrity
Websitehttps://mdxhealth.com/
FAQs
What is the current price of MDxHealth SA (MDXH)?
The current price of MDxHealth SA (MDXH) is 3.335.
What is the symbol of MDxHealth SA?
The ticker symbol of MDxHealth SA is MDXH.
What is the 52-week high of MDxHealth SA?
The 52-week high of MDxHealth SA is --.
What is the 52-week low of MDxHealth SA?
The 52-week low of MDxHealth SA is --.
What is the market capitalization of MDxHealth SA?
The market capitalization of MDxHealth SA is 165.07M.
What is the net income of MDxHealth SA?
The net income of MDxHealth SA is -38.07M.
Is MDxHealth SA (MDXH) currently rated as Buy, Hold, or Sell?
According to analysts, MDxHealth SA (MDXH) has an overall rating of --, with a price target of 6.040.
What is the Earnings Per Share (EPS TTM) of MDxHealth SA (MDXH)?
The Earnings Per Share (EPS TTM) of MDxHealth SA (MDXH) is -0.998.
Related Instruments
-0.24%
+0.42%
+0.69%
+0.20%
+0.65%
+2.90%
+1.20%
-0.27%
-0.14%
+0.28%
-0.52%
+0.15%
+0.79%
-0.28%
+0.08%
+0.66%
+1.73%
0.00%
+0.94%
+1.80%Popular Symbols
